Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Capital Expenditures (2019 - 2025)

Inventiva (IVA) posted quarterly Capital Expenditures of -$64521.7 for Q2 2025, up 76.5% year-over-year from -$36555.4 in Q2 2024, and up 76.5% quarter-over-quarter from -$274606.3 in Q2 2024.

Analysis

Inventiva (IVA) Capital Expenditures (2019 - 2025) Analysis & Trends

Inventiva's Capital Expenditures history runs 5 years deep, the most recent figure standing at -$64521.7 for Q2 2025.

  • In Q2 2025, Capital Expenditures rose 76.5% year-over-year to -$64521.7; the TTM figure through Jun 2025 stood at -$949979.4 (up 10.9% YoY), while the FY2022 annual figure was -$301993.2, down 67.08% from the prior year.
  • Capital Expenditures for Q2 2025 stood at -$64521.7, up from -$274606.3 in the prior quarter.
  • The five-year high for Capital Expenditures was -$49455.7 in Q1 2021, with the low at -$308858.1 in Q3 2022.
  • The 4-year median for Capital Expenditures is -$180747.4 (2021), against an average of -$188726.0.
  • The sharpest annual moves came in 2022 and 2025: Capital Expenditures plunged 67.08% in 2022, then surged 76.5% in 2025.
  • Inventiva's Capital Expenditures stood at -$180747.4 in 2021, then slumped by 67.08% to -$301993.2 in 2022, then grew by 9.07% to -$274606.3 in 2024, then soared by 76.5% to -$64521.7 in 2025.
  • Business Quant data shows IVA's Capital Expenditures at -$64521.7 in Q2 2025, -$274606.3 in Q2 2024, and -$301993.2 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Inventiva 893.85 Mn 893.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -64,521.70
Jun 30, 2024 -274,606.33
Dec 31, 2022 -301,993.22
Sep 22, 2022 -308,858.12
Dec 31, 2021 -180,747.41
Jun 30, 2021 -140,899.76
Mar 31, 2021 -49,455.68
Dec 31, 2019 -161,605.60